Researchers identified "GTP release-selective agonists" that prolong opioid analgesia while minimizing side effects. By targeting this specific receptor function, the study shows it is possible to maintain pain relief without tolerance, offering a promising pathway to safer pain management.

Published 1 day ago

Source: reddit.com

Researchers identified "GTP release-selective agonists" that prolong opioid analgesia while minimizing side effects. By targeting this specific receptor function, the study shows it is possible to maintain pain relief without tolerance, offering a promising pathway to safer pain management.

Researchers identified "GTP release-selective agonists" that prolong opioid analgesia while minimizing side effects. By targeting this specific receptor function, the study shows it is possible to maintain pain relief without tolerance, offering a promising pathway to safer pain management.

submitted by /u/Sciantifa
[link] [comments]

Categories

science

Read Original Article

Related Articles from reddit.com

Smart Glasses With 'Pet Translation' Smell Like Total BS

Bose open-sources its SoundTouch home theater smart speakers ahead of end-of-life | If companies insist on bricking gadgets, this is a better way to do it

OpenAI launches ChatGPT Health, encouraging users to connect their medical records

Potential bridge between narcissism and OCD: the drive for perfection may be the bridge connecting narcissism to obsessive-compulsive symptoms. For people with narcissistic traits, the inability to meet their own lofty standards is a primary driver of intrusive thoughts and compulsive behaviors.

Global cancer cases reached 18.5 million in 2023, doubling since 1990. With projections of 30 million cases by 2050, researchers warn the world is not ready for this surge, especially in low-income nations. Alarmingly, 40% of deaths remain tied to preventable risks like smoking and poor diet.

Tesla Door Design Is Targeted by New US Automotive Safety Bill